Compound · nmn
T2senolytics_antiaging

NMN (Nicotinamide Mononucleotide)

Direct precursor to nicotinamide adenine dinucleotide (NAD+) via the salvage pathway enzyme nicotinamide mononucleotide adenylyltransferase (NMNAT). Bypasses the rate-limiting NAMPT step when administered exogenously. Restores NAD+ levels that decline approximately 50% between ages 40 and 60. Elevated NAD+ activates SIRT1/3 deacetylases and PARP1 DNA repair enzymes, improves mitochondrial function, and enhances cellular energy metabolism.

Half-life
~3 hours
Bioavailability
~30% (oral, Slc12a8 transporter-mediated in gut)
Route
oral, sublingual
Evidence tier
T2 — Single-RCT or mechanistic
Optimization pillars
anti-aging · cellular-health · recovery
References
4 peer-reviewed
Dose ranges

Three tiers ordered by aggressiveness. Tier chips on every OPTIMIZE intervention let you filter the catalog by your evidence tolerance.

conservative
250 mg/day
NAD+ maintenance
moderate
500 mg/day
Standard longevity dose
aggressive
1000 mg/day
High-dose NAD+ restoration
Monitoring
  • fasting-glucose
  • hba1c
  • fasting-insulin
  • lipid-panel
  • alt
  • ast
  • homocysteine
  • hs-crp
Contraindications
  • active-cancer-uncontrolled
  • concurrent-nicotinamide-high-dose
  • pregnancy
References
  • PMID:27127236Long-term administration of nicotinamide mononucleotide mitigates age-associated physiological decline in miceCell Metab, 2016
  • PMID:31471192NMN supplementation increases NAD+ levels in healthy humansEndocr J, 2020
  • PMID:35927255NMN increases muscle insulin sensitivity in prediabetic womenScience, 2021
  • PMID:36482258MIB-626 (NMN formulation) in overweight adults: a randomized clinical trialJ Clin Endocrinol Metab, 2023
Notes

NMN is the NAD+ precursor that David Sinclair put on the map, for better and worse. The science is real — NAD+ declines with age, NMN restores it, and elevated NAD+ activates sirtuins and PARPs that are critical for DNA repair and mitochondrial function. The first human RCT data from Washington University showed insulin sensitivity improvements in prediabetic women. The MIB-626 trial confirmed dose-dependent NAD+ elevation. What the data does not yet show is whether taking NMN for 20 years extends human lifespan. The mouse data is compelling. The human translation is still in its first chapter. Also appears in the supplements category because the regulatory classification remains contested.

This is not medical advice

Discuss with a licensed clinician before starting, stopping, or changing any compound. This page documents what the research literature describes — it is not a prescription.

See NMN (Nicotinamide Mononucleotide) in a protocol matched to you

OPTIMIZE · a protocols.is product